The use of adenoviral vectors in gene therapy and vaccine approaches

The use of adenoviral vectors in gene therapy and vaccine approaches

Abstract Adenovirus was first identified in the 1950s and since then this pathogenic group of viruses has been explored and transformed into a genetic transfer vehicle. Modification or deletion of few genes are necessary to transform it into a conditionally or non-replicative vector, creating a vers...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Natália Meneses Araújo, Ileana Gabriela Sanchez Rubio, Nicholas Pietro Agulha Toneto, Mirian Galliote Morale, Rodrigo Esaki Tamura
Formaat:	Artikel
Taal:	English
Gepubliceerd in:	Sociedade Brasileira de Genética 2022-10-01
Reeks:	Genetics and Molecular Biology
Onderwerpen:	Adenovirus gene therapy monogenic diseases cancer vaccines
Online toegang:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572022000400108&tlng=en

Gelijkaardige items

Development of novel vaccine vectors: Chimpanzee adenoviral vectors
door: Jingao Guo, et al.
Gepubliceerd in: (2018-07-01)

Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
door: Lynda Coughlan
Gepubliceerd in: (2020-05-01)

Advances of Recombinant Adenoviral Vectors in Preclinical and Clinical Applications
door: Luca Scarsella, et al.
Gepubliceerd in: (2024-02-01)

Improving adenoviral vectors and strategies for prostate cancer gene therapy
door: Rodrigo Esaki Tamura, et al.
Gepubliceerd in: (2018-08-01)

DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2)
door: L. V. Cherenova, et al.
Gepubliceerd in: (2017-08-01)

DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 1)
door: L. V. Cherenova, et al.
Gepubliceerd in: (2017-05-01)

Construction and Immunological Evaluation of an Adenoviral Vector-Based Vaccine Candidate for Lassa Fever
door: Meirong Wang, et al.
Gepubliceerd in: (2021-03-01)

Progress in Adenoviral Capsid-Display Vaccines
door: Marija Vujadinovic, et al.
Gepubliceerd in: (2018-07-01)

Chimpanzee adenoviral vectors as vaccines – challenges to move the technology into the fast lane
door: Alessandra Vitelli, et al.
Gepubliceerd in: (2017-12-01)

Adenoviral vectors for gene therapy /
door: Curiel, David T., et al.
Gepubliceerd in: (2002)

Immunogenicity and Efficacy of Zika Virus Envelope Domain III in DNA, Protein, and ChAdOx1 Adenoviral-Vectored Vaccines
door: César López-Camacho, et al.
Gepubliceerd in: (2020-06-01)

Metformin and Cancer Hallmarks: Molecular Mechanisms in Thyroid, Prostate and Head and Neck Cancer Models
door: Mirian Galliote Morale, et al.
Gepubliceerd in: (2022-02-01)

Response Type and Host Species may be Sufficient to Predict Dose-Response Curve Shape for Adenoviral Vector Vaccines
door: John Benest, et al.
Gepubliceerd in: (2020-03-01)

A New Look at Vaccine Strategies Against PPRV Focused on Adenoviral Candidates
door: José M. Rojas, et al.
Gepubliceerd in: (2021-09-01)

Differential Biodistribution of Adenoviral-Vectored Vaccine Following Intranasal and Endotracheal Deliveries Leads to Different Immune Outcomes
door: Vidthiya Jeyanathan, et al.
Gepubliceerd in: (2022-06-01)

Construction and application of adenoviral vectors
door: Hongbo Zhang, et al.
Gepubliceerd in: (2023-12-01)

Editorial: Adenoviral Infection and Immunity, and Adenoviral Vectors for Gene Therapy Applications
door: Qiwei Zhang, et al.
Gepubliceerd in: (2022-03-01)

The Role of Chromatin in Adenoviral Vector Function
door: Carmen M. Wong, et al.
Gepubliceerd in: (2013-06-01)

Corrigendum: Differential biodistribution of adenoviral-vectored vaccine following intranasal and endotracheal deliveries leads to different immune outcomes
door: Vidthiya Jeyanathan, et al.
Gepubliceerd in: (2023-02-01)

Adenoviral-Vectored Centralized Consensus Hemagglutinin Vaccine Provides Broad Protection against H2 Influenza a Virus
door: Erika M. Petro-Turnquist, et al.
Gepubliceerd in: (2022-06-01)

Intranasally Delivered Adenoviral Vector Protects Chickens against Newcastle Disease Virus: Vaccine Manufacturing and Stability Assessments for Liquid and Lyophilized Formulations
door: Omar Farnós, et al.
Gepubliceerd in: (2023-12-01)

Immunologic Dose-Response to Adenovirus-Vectored Vaccines in Animals and Humans: A Systematic Review of Dose-Response Studies of Replication Incompetent Adenoviral Vaccine Vectors when Given via an Intramuscular or Subcutaneous Route
door: Sara Afrough, et al.
Gepubliceerd in: (2020-03-01)

Single-cycle adenovirus vectors in the current vaccine landscape
door: Michael Barry
Gepubliceerd in: (2018-02-01)

Significance of Preexisting Vector Immunity and Activation of Innate Responses for Adenoviral Vector-Based Therapy
door: Wen-Chien Wang, et al.
Gepubliceerd in: (2022-12-01)

Adenoviral Keratoconjunctivitis
door: Alexander Bialasiewicz
Gepubliceerd in: (2007-04-01)

Adenoviral Vectors Armed with Cell Fusion-Inducing Proteins as Anti-Cancer Agents
door: Joshua Del Papa, et al.
Gepubliceerd in: (2017-01-01)

The Use of Viral Vectors for Gene Therapy and Vaccination in Tuberculosis
door: Dulce Mata-Espinosa, et al.
Gepubliceerd in: (2023-10-01)

TLR4 and SARM1 modulate survival and chemoresistance in an HPV-positive cervical cancer cell line
door: Mirian Galliote Morale, et al.
Gepubliceerd in: (2022-04-01)

Innate Immune Responses to Chimpanzee Adenovirus Vector 155 Vaccination in Mice and Monkeys
door: Catherine Collignon, et al.
Gepubliceerd in: (2020-11-01)

Developments in Viral Vector-Based Vaccines
door: Takehiro Ura, et al.
Gepubliceerd in: (2014-07-01)

Recent Advances in the Development of Adenovirus-Vectored Vaccines for Parasitic Infections
door: Cal Koger-Pease, et al.
Gepubliceerd in: (2023-02-01)

Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes
door: Groitl Peter, et al.
Gepubliceerd in: (2011-09-01)

Tropism-Modification Strategies for Targeted Gene Delivery Using Adenoviral Vectors
door: Andrew H. Baker, et al.
Gepubliceerd in: (2010-10-01)

Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
door: Adam Berg, et al.
Gepubliceerd in: (2021-10-01)

Current development in adenoviral vectors for cancer immunotherapy
door: Greyson Willis Grossman Biegert, et al.
Gepubliceerd in: (2021-12-01)

Immunogenicity and clinical features relating to BNT162b2 messenger RNA COVID-19 vaccine, Ad26.COV2.S and ChAdOx1 adenoviral vector COVID-19 vaccines: a systematic review of non-interventional studies
door: Chinonyerem O. Iheanacho, et al.
Gepubliceerd in: (2022-03-01)

The prevalence of adenoviral conjunctivitis at the Clinical Hospital of the State University of Campinas, Brazil
door: Roberto Damian Pacheco Pinto, et al.
Gepubliceerd in: (2015-11-01)

Extracellular vesicles provide a capsid-free vector for oncolytic adenoviral DNA delivery
door: Heikki Saari, et al.
Gepubliceerd in: (2020-01-01)

Application of adenovirus vector in cancer gene therapyand vaccination
door: Xie Qian, et al.
Gepubliceerd in: (2021-03-01)

The Design and Development of a Multi-HBV Antigen Encoded in Chimpanzee Adenoviral and Modified Vaccinia Ankara Viral Vectors; A Novel Therapeutic Vaccine Strategy against HBV
door: Senthil K. Chinnakannan, et al.
Gepubliceerd in: (2020-04-01)